ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,835
0,25%
Bitcoin
59 498,60
0,64%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. abrdn Life Sciences Investors (HQL)

  7. abrdn Life Sciences Investors (HQL) Actualités

HQL abrdn Life Sciences Investors

13,48
0,20 (1,51%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
abrdn Life Sciences Investors HQL NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,20 1,51% 13,48 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
13,41 13,33 13,4901 13,48 13,28
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/2/202418:37EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
07/2/202413:55EDGAR2Form SC 13D/A - General statement of acquisition of..
12/1/202417:41EDGAR2Form SC 13D/A - General statement of acquisition of..
04/1/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202313:54EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/12/202320:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/12/202320:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202316:57EDGAR2Form N-CEN - Annual Report for Registered Investment..
11/12/202322:11EDGAR2Form N-CSR - Certified Shareholder Report
15/11/202321:13EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
06/11/202321:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202321:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/10/202322:57BWTekla Funds Approve New Investment Advisory Agreements With..
14/10/202300:26BWTekla Funds Implore Shareholders of THQ and THW to Vote..
05/10/202320:05BWTekla Funds Urge Shareholders to Vote Immediately to..
29/9/202316:35BWTekla Life Sciences Investors Paid Distribution
27/9/202315:33EDGAR2Form POS EX - Post-effective amendment adding exhibits to..
25/9/202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202314:51BWTekla Funds Announce Adjournment of Special Meetings and..
12/9/202323:06EDGAR2Form 8-K - Current report
30/8/202320:39BWTekla Funds Announce Second Adjournment of Special Meetings..
28/8/202321:31EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
25/8/202320:35EDGAR2Form N-CSR/A - Certified Shareholder Report: [Amend]
22/8/202321:35EDGAR2Form N-CSR/A - Certified Shareholder Report: [Amend]
15/8/202315:55BWTekla Life Sciences Investors Declares Distribution
14/8/202321:10BWTekla Funds Announce Adjournment of Special Meetings
04/8/202318:05EDGAR2Form N-PX - Annual Report of proxy voting record of..
30/6/202316:35BWTekla Life Sciences Investors Paid Distribution
20/6/202323:48BWTekla Capital Management LLC Announces Proposed Transaction
15/5/202316:36BWTekla Life Sciences Investors Declares Distribution

Dernières Valeurs Consultées

NYSE
HQL
abrdn Life Sciences Inve...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés